Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

GERN – Geron Corporation

Geron Corporation
GERN
$1.17
Name : Geron Corporation
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $745,194,048.00
EPSttm : -0.21
finviz dynamic chart for GERN
Geron Corporation
$1.17
1.74%
$0.02

Float Short %

11.26

Margin Of Safety %

Put/Call OI Ratio

0.1

EPS Next Q Diff

-0.01

EPS Last/This Y

0.13

EPS This/Next Y

0.08

Price

1.17

Target Price

3.39

Analyst Recom

2.1

Performance Q

-18.18

Relative Volume

0.92

Beta

0.73

Ticker: GERN




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04GERN1.430.150.0087781
2025-07-07GERN1.3750.150.0687828
2025-07-08GERN1.390.150.6288011
2025-07-09GERN1.440.150.2588239
2025-07-10GERN1.3850.150.0088476
2025-07-11GERN1.3150.150.0188858
2025-07-14GERN1.330.150.2289084
2025-07-15GERN1.2650.150.0789072
2025-07-16GERN1.260.150.0089186
2025-07-17GERN1.290.150.2289214
2025-07-18GERN1.240.150.1289292
2025-07-21GERN1.2250.130.0285751
2025-07-22GERN1.2850.130.0085735
2025-07-23GERN1.320.130.0286087
2025-07-24GERN1.2750.130.0086240
2025-07-25GERN1.2550.130.0085719
2025-07-28GERN1.140.130.0685794
2025-07-29GERN1.1350.130.1186515
2025-07-30GERN1.0950.130.4787018
2025-07-31GERN1.1450.100.1380436
2025-08-01GERN1.1750.100.0180748
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04GERN1.4371.539.9-0.12
2025-07-07GERN1.3771.546.6-0.12
2025-07-08GERN1.3971.540.5-0.12
2025-07-09GERN1.4471.538.2-0.12
2025-07-10GERN1.3871.546.4-0.12
2025-07-11GERN1.3271.550.9-0.12
2025-07-14GERN1.3471.540.5-0.12
2025-07-15GERN1.2671.548.6-0.12
2025-07-16GERN1.2671.541.7-0.12
2025-07-17GERN1.2971.540.4-0.12
2025-07-18GERN1.2571.545.6-0.12
2025-07-21GERN1.2371.543.1-0.12
2025-07-22GERN1.2871.537.5-0.12
2025-07-23GERN1.3371.537.7-0.12
2025-07-24GERN1.2871.546.2-0.12
2025-07-25GERN1.2671.543.8-0.13
2025-07-28GERN1.1569.251.9-0.13
2025-07-29GERN1.1369.243.6-0.13
2025-07-30GERN1.1069.245.3-0.13
2025-07-31GERN1.1569.236.6-0.13
2025-08-01GERN1.1767.240.1-0.14
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04GERN0.425.0010.81
2025-07-07GERN0.424.9910.81
2025-07-08GERN0.424.9910.81
2025-07-09GERN0.424.9910.81
2025-07-10GERN0.424.9910.81
2025-07-11GERN0.424.9910.44
2025-07-14GERN0.425.2310.44
2025-07-15GERN0.425.2310.44
2025-07-16GERN0.425.2310.44
2025-07-17GERN0.425.2310.44
2025-07-18GERN0.425.2310.44
2025-07-21GERN0.425.2310.44
2025-07-22GERN0.425.2310.44
2025-07-23GERN0.425.2310.44
2025-07-24GERN0.425.2310.44
2025-07-25GERN0.425.2311.26
2025-07-28GERN0.424.9911.26
2025-07-29GERN0.424.9911.26
2025-07-30GERN0.424.9911.26
2025-07-31GERN0.424.9911.26
2025-08-01GERN0.424.9911.26
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.03

Avg. EPS Est. Current Quarter

-0.03

Avg. EPS Est. Next Quarter

-0.04

Insider Transactions

0.42

Institutional Transactions

4.99

Beta

0.73

Average Sales Estimate Current Quarter

46

Average Sales Estimate Next Quarter

52

Fair Value

Quality Score

43

Growth Score

56

Sentiment Score

13

Actual DrawDown %

78.1

Max Drawdown 5-Year %

-78.4

Target Price

3.39

P/E

Forward P/E

PEG

P/S

6.41

P/B

2.78

P/Free Cash Flow

EPS

-0.21

Average EPS Est. Cur. Y​

-0.14

EPS Next Y. (Est.)

-0.06

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-119.54

Relative Volume

0.92

Return on Equity vs Sector %

-75.6

Return on Equity vs Industry %

-56.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

40.1
Geron Corporation
Sector: Healthcare
Industry: Biotechnology
Employees: 229
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
stock quote shares GERN – Geron Corporation Stock Price stock today
news today GERN – Geron Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch GERN – Geron Corporation yahoo finance google finance
stock history GERN – Geron Corporation invest stock market
stock prices GERN premarket after hours
ticker GERN fair value insiders trading